Latest News and Press Releases
Want to stay updated on the latest news?
-
iRhythm misled investors by promoting Zio AT as a real-time monitor for high-risk patients, inflating stock prices that dropped when the truth emerged.
-
Robbins LLP is Investigating Allegations that 3D Systems Corporation (DDD) Misled Investors Regarding the Company's Business Prospects
-
Robbins LLP is Investigating Allegations that Tempus AI, Inc. (TEM) Misled Investors Regarding its Business Prospects
-
Robbins LLP is Investigating Allegations that Rocket Pharmaceuticals, Inc. (RCKT) Misled Investors Regarding the Viability and Efficacy of RP-A501
-
Robbins LLP is Investigating Allegations that Civitas Resources, Inc. (CIVI) Misled Investors Regarding the Company's Production Capabilities
-
Robbins LLP is Investigating Allegations that West Pharmaceutical Services, Inc. (WST) Misled Investors Regarding the Company's Business Prospects
-
Robbins LLP is Investigating Allegations that Vestis Corporation (VSTS) Misled Investors regarding Customer Growth
-
Robbins LLP is Investigating Allegations that KnowBe4, Inc. (KNBE) Misled Investors Regarding its Acquisition by Vista Equity Partners Management LLC
-
Robbins LLP is Investigating Allegations that Fortrea Holdings, Inc. (FTRE) Misled Investors Regarding the Progress of its Pre-Spin Projects
-
Robbins LLP is Investigating Allegations that UroGen Pharma Ltd. (URGN) Failed to Conduct a Proper Trial for its Lead Drug Candidate